Ahmed Ayaz, Khan Anum Khalid, Anwar Ayaz, Ali Syed Abid, Shah Muhammad Raza
Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi, 75270, Pakistan.
Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi, 75270, Pakistan.
Microb Pathog. 2016 Sep;98:50-6. doi: 10.1016/j.micpath.2016.06.016. Epub 2016 Jun 16.
Klebsiella pneumoniae (K. pneumoniae) is one of the major pathogen associated with nosocomial infections, especially catheter associated urinary tract infections which involved biofilm formation. This study was designed to evaluate the antibiofilm efficacy of gold nanoparticle conjugated with chlorhexidine (Au-CHX) against K. pneumoniae isolates. Au-CHX was synthesized and analyzed for stability by using UV-Visible spectrophotometry, atomic force microscopy (AFM), fourier transform infrared spectroscopy (FT-IR) and electrospray ionization mass spectroscopy (ESI-MS). Biofilm inhibition and eradication was performed by crystal violet, 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays and further confirmed by florescence and AFM microscopy. Au-CHX showed the maxima surface plasmon resonance (SPR) band at 535 nm, spherical morphology and polydispersity with size in the range of 20-100 nm. The micro molar concentrations (i.e. 25 and 100 μM) of Au-CHX completely inhibited the biofilm formation and metabolic activity within biofilms of K. pneumoniae reference and three tested clinical isolates, respectively. Time dependant biofilm inhibition assay showed that Au-CHX inhibited the early stage of biofilm formation. While at 75 and 100 μM concentrations, it also eradicated the established biofilms of K. pneumoniae isolates as compared to 2 mM chlorhexidine. Reduced florescence signals and surface roughness during microscopic analysis further confirms the antibiofilm activity of Au-CHX against K. pneumoniae ATCC13882 and clinical isolates. Thus it is concluded that chlorhexidine coated gold nanoparticle not only inhibits the biofilm formation of K. pneumoniae ATCC and clinical isolates but also eradicated the preformed biofilm.
肺炎克雷伯菌是与医院感染相关的主要病原体之一,尤其是与涉及生物膜形成的导管相关尿路感染有关。本研究旨在评估与洗必泰结合的金纳米颗粒(Au-CHX)对肺炎克雷伯菌分离株的抗生物膜效果。合成了Au-CHX,并通过紫外可见分光光度法、原子力显微镜(AFM)、傅里叶变换红外光谱(FT-IR)和电喷雾电离质谱(ESI-MS)分析其稳定性。通过结晶紫、3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)试验进行生物膜抑制和根除,并通过荧光和AFM显微镜进一步确认。Au-CHX在535nm处显示出最大表面等离子体共振(SPR)带,呈球形形态且多分散,尺寸在20-100nm范围内。Au-CHX的微摩尔浓度(即25和100μM)分别完全抑制了肺炎克雷伯菌参考菌株和三种测试临床分离株生物膜的形成以及生物膜内的代谢活性。时间依赖性生物膜抑制试验表明,Au-CHX抑制生物膜形成的早期阶段。与2mM洗必泰相比,在75和100μM浓度下,它还能根除肺炎克雷伯菌分离株已形成的生物膜。微观分析过程中荧光信号减弱和表面粗糙度降低进一步证实了Au-CHX对肺炎克雷伯菌ATCC13882和临床分离株的抗生物膜活性。因此得出结论,洗必泰包被的金纳米颗粒不仅抑制肺炎克雷伯菌ATCC和临床分离株的生物膜形成,还能根除预先形成的生物膜。